Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2015; 5(3): 001-005


Cell viability, anti-proliferation and antioxidant activities of Sideritis syriaca, Tanacetum argenteum subsp. argenteum and Achillea aleppica subsp. zederbaueri on human breast cancer cell line (MCF-7)

Onder Yumrutas, Serdar Oztuzcu, Mustafa Pehlivan, Nilgun Ozturk, I. Eroz Poyraz, Yusuf Ziya Iğci, M. Ozgur Cevik, Ibrahim Bozgeyik, Ayse Fatma Aksoy, Haydar Bagıs, Ahmet Arslan.




Abstract

The breast cancer is one of the most common types of cancer. Many scientists have focused on the treatment of this disease for a long time by studying anti-cancer activities of plant extracts as well as synthetics. Lamiaceae and Asteraceae have been used in anticancer studies due to their phytochemical content. The genus Sideritis, Achillea and Tanacetum are the members of these families. Sideritis, Achillea and Tanacetum are used as herbal medication for the treatment of variety of diseases. In present study, we demonstrated the biological activity of Sideritis syriaca (SS), Achillea aleppica subsp. zederbaueri (AAZ) and Tanacetum argenteum supsp argenteum (TAA) methanol extracts on cell viability of the breast cancer line MCF7. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to determine the cell viability and proliferation of MCF7 cells. In a dose dependent manner, methanol extracts (0, 1, 5, 25, 100 and 250 µg/ml) of SS, AZZ and TAA were examined on MCF7, and viability of cells were determined with MTT staining. Especially, concentrations in 100 and 250 µg/ml of extracts decreased the cell viability (p

Key words: Cancer cell line, Cell viability, Antiproliferation, Antioxidant, Sideritis, Tanacetum, Achillea






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.